Neogenomics Inc (NEO) 8.40 $NEO Zacks.com featured

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 8:07 AM

Neogenomics Inc (NEO) 8.40 $NEO

Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 161.98 (-9.50), NEO: 8.40 (-0.62), CVGI: 4.47 (+0.02)

Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 161.98 (-9.50), NEO: 8.40 (-0.62), CVGI: 4.47 (+0.02)

Bet on These 5 Liquid Stocks for Fat Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:23PM CDT
An efficient company with a favorable liquidity level may prove to be a profitable addition to one's portfolio.
NEO: 8.40 (-0.62), SLAB: 49.59 (-1.19), NTGR: 46.26 (-0.91), LPLA: 24.75 (-0.99), AMPH: 16.13 (-0.30)

The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
CSGP: 209.11 (-5.46), AMSF: 64.50 (+0.02), NEO: 8.40 (-0.62), HIIQ: 4.55 (-0.62), AHS: 39.97 (-1.01)

7 Stocks with Recent Price Strength to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:24AM CDT
Stocks that have recently seen price strength have high chances of carrying the momentum forward.
AMSF: 64.50 (+0.02), NEO: 8.40 (-0.62), HIIQ: 4.55 (-0.62), AHS: 39.97 (-1.01), COHR: 94.50 (-1.81), NANO: 18.72 (-0.18)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 76.68 (-0.95), ANIP: 52.05 (-1.64), NEO: 8.40 (-0.62), RTRX: 17.40 (-0.30)

Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:42AM CDT
Neogenomics (NEO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
NEO: 8.40 (-0.62)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 76.68 (-0.95), HSKA: 35.56 (-0.56), ANIP: 52.05 (-1.64), NEO: 8.40 (-0.62)

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
PR Newswire - Wed Apr 27, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter of 2016.
NEO: 8.40 (-0.62)

Investor Calendar Invites You to the NeoGenomics First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:05PM CDT
FORT MYERS, FL / ACCESSWIRE / April 26, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 11:00 AM Eastern Time.
NEO: 8.40 (-0.62)

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016
PR Newswire - Mon Apr 11, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its first quarter 2016 financial results on Wednesday April 27, 2016.
NEO: 8.40 (-0.62)

Pressure BioSciences' SCIEX Deal Could Dramatically Accelerate Revenue
ACCESSWIRE - Thu Jan 28, 8:26AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO). PBIO is a worldwide leader in the development and sale of pressure cycling technology (PCT)-based sample preparation systems to the life sciences research market. Under the agreement, the companies will jointly promote PBIO's PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation, a crucial step performed by hundreds of thousands of research laboratories worldwide. This combination of technologies could result in superior biological insights and discoveries in the life sciences industry, and in rapid and dramatic revenue growth for PBIO.
NSTG: 13.19 (-0.18), A: 45.36 (-0.73), TMO: 151.80 (-2.35), NEO: 8.40 (-0.62), QGEN: 21.71 (-0.49), DHR: 99.31 (-1.08), WAT: 138.04 (-2.01)

NeoGenomics Schedules its Q4 2015 and full year 2015 Earnings Release for March 1, 2016
PR Newswire - Tue Jan 26, 6:00AM CST
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its fourth quarter 2015 and full year 2015 financial results on Tuesday, March 1, 2016.
NEO: 8.40 (-0.62)

Healthcare Sector Stocks Technical Coverage -- Neogenomics, OraSure Technologies, Tetraphase Pharma, and LeMaitre Vascular
ACCESSWIRE - Thu Jan 14, 7:03AM CST
NEW YORK, NY / ACCESSWIRE / January 14, 2016 / Park Lane Advisor has initiated coverage on the following equities: Neogenomics Inc. (NASDAQ: NEO), OraSure Technologies Inc. (NASDAQ: OSUR), Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH), and LeMaitre Vascular Inc. (NASDAQ: LMAT). Free research report on Neogenomics can be accessed at http://www.parklaneadvisor.com/ On Wednesday, January 13, 2016, the NASDAQ Composite ended at 4,526.06, down 3.41%, the Dow Jones Industrial Average declined 2.21%, to finish the day at 16,151.41, and the S&P 500 closed at 1,890.28, down 2.50%. The losses were broad based as all the sectors ended the session in negative. Register for your complimentary reports at the links given below.
TTPH: 3.94 (-0.17), NEO: 8.40 (-0.62), LMAT: 15.03 (-0.06), OSUR: 7.78 (-0.13)

Dycom & 4 Other Surprise Champions of 2015
Zacks Equity Research - Zacks Investment Research - Mon Jan 04, 4:12PM CST
Prepare your portfolio with these surprise winners of 2015 that look set to win in 2016 as well.
NEO: 8.40 (-0.62), GIG: 2.16 (-0.46), DY: 84.76 (-2.34), HQCL: 12.61 (-0.26), SWHC: 21.41 (-0.60)

NeoGenomics Completes Acquisition of Clarient, Inc.
PR Newswire - Wed Dec 30, 3:10PM CST
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive cancer diagnostic testing to hospitals, physicians and the pharmaceutical industry, was a unit of GE Healthcare's Life Sciences business. Based in Aliso Viejo, California and Houston, Texas, Clarient has approximately 415 employees and reported 2014 revenue of approximately $127 million.
NEO: 8.40 (-0.62)

Insider Bets Paying Off At NEO As New 52-Week High Reached
MarketNewsVideo.com - Tue Dec 22, 12:37PM CST
In trading on Tuesday, shares of NeoGenomics Inc touched a new 52-week high of $8.48/share. That's a 154.65% rise, or $5.15 per share from the 52-week low of $3.33 set back on 01/22/2015.
NEO: 8.40 (-0.62)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Millrose Faces Class Action: Blame Game in Motion

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Mili and Egnyte Transform Financial Advice Delivery

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Hemlo Mining's Q3 2026: Challenges and New Solutions

Resilience in the Face of Operational Setbacks Here's a peek into Hemlo Mining's latest exploits. They're riding a rollercoaster of operational challenges, yet still managing to chug along with stable gold production. It's like trying to drive uphill with a flat tire, but somehow, Hemlo's trucking along without missing too much of a beat. The numbers are in, and despite a...

Dan-O's Seasoning Bags $25M to Spice Up Global Kitchens

Spicing Up The Investment Scene Who would've thought a humble seasoning mix could steal the show in the investment world, eh? Dan-O's Seasoning, that quirky little flavor brand from Louisville, just pulled a $25 million rabbit out of the hat with an investment from The Newcastle Network. That's news worth chewing on. From Farmers Market to Flavor Giant Let's flash back a...

Equity Alerts: Unraveling the Latest M&A Surprises

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Minesto Joins Sweden-Indonesia Partnership in Energy Shift

Minesto's Big Splash in Indonesia's Energy Transition Here we go, folks. Minesto's taking the plunge into Indonesia's uncharted tidal waters under a Sweden-backed partnership. This Swedish underdog in ocean energy is ready to shake things up and ride the Indonesian currents, thanks to the Sweden-Indonesia Sustainability Partnership. Now, why should this matter to you, the...

Microencapsulation Market to Hit $24B by 2031

Think about wrapping a tiny gift inside a bubble that's not only protective but also dissolves at just the right moment. That, my friends, is microencapsulation summed up—and it's becoming a big deal. With the market poised to jump from $16.90 billion in 2026 to a whopping $24.02 billion by 2031, at a steady clip of 7.3% annually, there's a lot for investors to chew on...

European Flavors: A Halloween Food Revolution

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

New American Perspectives Shines at HIFF 2026

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Highlight's Pulse Offers Real-Time Consumer Insights

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...